Validation of the Hebrew Version of the Montreal Affective Voices.
Primary Purpose
Parkinson's Disease, Depression
Status
Unknown status
Phase
Locations
Israel
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Parkinson's Disease
Eligibility Criteria
Inclusion Criteria:
- Healthy group
- Parkinson's disease
- Major depressive disorder
- All participants will be competent and willing to give written informed consent. Patients over 65 and/or suspected to have a cognitive decline will be tested by the Mini-mental test and will be included in the study only if the score is above 26.
Exclusion Criteria:
- Non-competent or unable to give written informed consent
Sites / Locations
- Hadassah Medical Organization,
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Arm Label
healthy control group
Parkinson's disease patients
Major depressive disorder patients
Arm Description
Young (20-49) and Older (50-70) healthy group (n=60)
(n=30).
(n=30).
Outcomes
Primary Outcome Measures
Verifying the results achieved by Belin et al (2008) when using the Hebrew version of the MAV bursts in healthy control groups.
Secondary Outcome Measures
Full Information
NCT ID
NCT01512732
First Posted
January 15, 2012
Last Updated
January 22, 2012
Sponsor
Hadassah Medical Organization
1. Study Identification
Unique Protocol Identification Number
NCT01512732
Brief Title
Validation of the Hebrew Version of the Montreal Affective Voices.
Study Type
Observational
2. Study Status
Record Verification Date
January 2012
Overall Recruitment Status
Unknown status
Study Start Date
February 2012 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hadassah Medical Organization
4. Oversight
5. Study Description
Brief Summary
Today, no non-verbal auditory stimuli that assess mental processing are available in Israel. The goal of this study is to make available a validated set of auditory stimuli in Israel. We created a computerized Hebrew version of the Montreal Affective Voices (MAV). The MAV is a novel tool for assessing mental processing. The MAV consists of 90 nonverbal affect bursts corresponding to nine different emotions (such as anger, fear, happiness etc.) recorded by ten different actors. The uniqueness of these affective bursts is that they do not contain verbal context, but rather express affective moods using the vowel /a/ (as in "apple"). In this study, the investigators will verify the new Hebrew version of MAV in healthy control groups. Next, the investigators will compare the mental processing ability in young vs. old population, using the MAV test. In addition, the investigators will assess mental processing in two pathologic study groups (Parkinson's disease, major depressive disorder) using the MAV test. The investigators intend to use the MAV tool in future research in Parkinson's disease and depression.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson's Disease, Depression
7. Study Design
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
healthy control group
Arm Description
Young (20-49) and Older (50-70) healthy group (n=60)
Arm Title
Parkinson's disease patients
Arm Description
(n=30).
Arm Title
Major depressive disorder patients
Arm Description
(n=30).
Primary Outcome Measure Information:
Title
Verifying the results achieved by Belin et al (2008) when using the Hebrew version of the MAV bursts in healthy control groups.
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy group
Parkinson's disease
Major depressive disorder
All participants will be competent and willing to give written informed consent. Patients over 65 and/or suspected to have a cognitive decline will be tested by the Mini-mental test and will be included in the study only if the score is above 26.
Exclusion Criteria:
Non-competent or unable to give written informed consent
Study Population Description
healthy group, Parkinson's disease patients, Major depressive disorder patients.
Sampling Method
Non-Probability Sample
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Renana Eitan, Dr
Phone
972-050-4048165
Email
renanaeitan@gmail.com
Facility Information:
Facility Name
Hadassah Medical Organization,
City
Jerusalem,
Country
Israel
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hadas Lemberg, PhD
Phone
00 972 2 6777572
Email
lhadas@hadassah.org.il
First Name & Middle Initial & Last Name & Degree
Renana Eitan, MD
12. IPD Sharing Statement
Learn more about this trial
Validation of the Hebrew Version of the Montreal Affective Voices.
We'll reach out to this number within 24 hrs